Rexcin Pharmaceuticals

Delhi, India Founded: 2003 • Age: 23 yrs
Manufactures and markets dermatological pharmaceutical products.

About Rexcin Pharmaceuticals

Rexcin Pharmaceuticals is a Healthcare company based in Delhi (India) founded in 2003. It manufactures and markets dermatological pharmaceutical products. It operates on a B2B model. The company has 1 employees. Its Indian entity Rexcin Pharmaceuticals Private Limited reported revenue of β‚Ή8.57 Cr. Its focus areas include Pharmaceuticals, Dermatology and Product Manufacturing and Marketing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Rexcin Pharmaceuticals manufactures and markets dermatological pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, dermatology, and product manufacturing and marketing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹8.57 Cr

    FY 2025 · +15% YoY

  • Net Profit
    ₹2.05 Cr

    FY 2025 · 24% margin

  • EBITDA
    ₹2.81 Cr

    FY 2025 · 33% margin

  • Employee Count
    1

Board of directors of Rexcin Pharmaceuticals Private Limited (Rexcin Pharmaceuticals)

Rexcin Pharmaceuticals Private Limited is the primary company behind Rexcin Pharmaceuticals. The board of Rexcin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Pradeep Saxena, appointed in 2013. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pradeep Saxena
DIN 03535793
Director31 Jul 201313 yrs 3 moRexcin Pharmaceuticals Private Limited
Satinder Pal Singh
DIN 02676056
Director15 Jul 201511 yrs 4 moRexcin Pharmaceuticals Private Limited

Financials of Rexcin Pharmaceuticals

Figures of Rexcin Pharmaceuticals Private Limited, the primary company behind Rexcin Pharmaceuticals, for FY 2025. Revenue was ₹8.57 Cr (+15% year on year). Net profit was ₹2.05 Cr (24% margin). EBITDA was ₹2.81 Cr (33% margin). Revenue has grown at a compounded annual rate of -3% over three years and -8% over five years.

  • ₹8.57 CrRevenue · FY 2025 · +15% YoY
  • ₹2.05 CrNet profit · 24% margin
  • ₹2.81 CrEBITDA · 33% margin
  • ₹2 LakhPaid-up capital
  • 1Employees (provident fund records)
  • -3%Revenue CAGR, 3 years
  • -8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rexcin Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Rexcin Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Rexcin Pharmaceuticals

Rexcin Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Rexcin Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rexcin Pharmaceuticals

Rexcin Pharmaceuticals was founded in 2003.

Rexcin Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Rexcin Pharmaceuticals has 1 employees.

The primary company behind Rexcin Pharmaceuticals, Rexcin Pharmaceuticals Private Limited, reported revenue of β‚Ή8.57 Cr for FY 2025, up 15% year on year.

Rexcin Pharmaceuticals manufactures and markets dermatological pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, dermatology, and product manufacturing and marketing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Rexcin Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Rexcin Pharmaceuticals operates through Rexcin Pharmaceuticals Private Limited.

The legal entities of Rexcin Pharmaceuticals currently have 2 directors, including Satinder Pal Singh, Pradeep Saxena.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available